MONIQUE HUTCHINSON: Open Payments
NPI 1154701399 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,409 in 99 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $4,316 · 2025 $2,409
Food & beverage: $2,409
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 11 | $460 |
| Vanda Pharmaceuticals Inc. | 11 | $389 |
| Neurocrine BioSciences, Inc. | 10 | $274 |
| ABBVIE INC. | 16 | $267 |
| Alkermes, Inc. | 9 | $176 |
| Axsome Therapeutics, Inc. | 7 | $170 |
| Otsuka America Pharmaceutical, Inc. | 9 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $150 |
| Lundbeck LLC | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
Products named: SPRAVATO, HETLIOZ, INGREZZA, VRAYLAR, Auvelity, ARISTADA, CAPLYTA, REXULTI.
Industry payments across CA — which companies pay providers there.
